Diagnos Inc.
ADK.V
TSX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -2.74M | -2.47M | -2.28M | -2.31M | -2.25M |
Total Depreciation and Amortization | 93.80K | 96.70K | 94.40K | 92.10K | 84.60K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 587.50K | 542.20K | 531.90K | 515.50K | 502.80K |
Change in Net Operating Assets | -63.50K | 8.10K | -34.70K | 115.10K | 186.10K |
Cash from Operations | -2.12M | -1.82M | -1.69M | -1.59M | -1.48M |
Capital Expenditure | -9.60K | -7.90K | -7.10K | -8.10K | -20.10K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -1.85M | -1.25M | -145.90K | -3.80K | 219.10K |
Cash from Investing | -1.86M | -1.25M | -152.90K | -11.90K | 199.00K |
Total Debt Issued | 0.00 | 0.00 | 0.00 | 843.80K | 1.08M |
Total Debt Repaid | -159.70K | -155.30K | -146.10K | -133.10K | -234.40K |
Issuance of Common Stock | 5.90M | 5.00M | 2.68M | 1.64M | 1.08M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -298.10K | -302.50K | -286.40K | -262.50K | -260.60K |
Cash from Financing | 3.97M | 3.33M | 1.65M | 1.55M | 1.24M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -16.40K | 259.30K | -190.00K | -58.00K | -43.30K |